





Suicide trends in the early months of the COVID-19 pandemic: Interrupted time series analysis of preliminary 
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The COVID-19 pandemic is having profound mental health consequences for many people. Concerns have 




We sourced real-time suicide data from around the world via a systematic internet search and recourse to 
our networks and the published literature. We used interrupted time series analysis to model the trend in 
monthly suicides prior to COVID-19 in each country/area-within-country, comparing the expected number of 
suicides derived from the model with the observed number of suicides in the early months of the pandemic. 
Countries/areas-within countries contributed data from at least 1 January 2019 to 31 July 2020 and 
potentially from as far back as 1 January 2016 until as recently as 31 October 2020. We conducted a primary 
analysis in which we treated 1 April to 31 July 2020 as the COVID-19 period, and two sensitivity analyses in 





We sourced data from 21 countries (high income [n=16], upper-middle income [n=5]; whole country [n=10], 
area(s)-within-the-country [n=11]). In general, there does not appear to have been a significant increase in 
suicides since the pandemic began in the countries for which we had data. In fact, in a number of 




This is the first study to examine suicides occurring in the context of the COVID-19 pandemic in multiple 
countries. It offers a consistent picture, albeit from high- and upper-middle income countries, of suicide 
numbers largely remaining unchanged or declining in the early months of the pandemic. We need to remain 
vigilant and be poised to respond if the situation changes as the longer-term mental health and economic 











RESEARCH IN CONTEXT 
 
Evidence before this study 
 
Evidence on the relationship between the COVID-19 pandemic and suicide before this study predominantly 
came from studies that relied on unofficial data sources and/or did not account for pre-existing trends. We 
have been conducting a living systematic review since the onset of the pandemic, searching the literature 
(including pre-prints) on a daily basis via PubMed, Scopus, medRxiv, bioRxiv, the COVID-19 Open Research 
Dataset (CORD-19) by Semantic Scholar and the Allen Institute for AI, and the WHO COVID-19 database. As at 
8 December we had identified 21 reports but only five of these accounted for temporal trends in suicides 
(e.g., by using time series analyses). Three of these studies found no change in suicide numbers in Greece, 
Australia (Queensland) and the United States (Massachusetts), and the fourth identified a decrease in Peru. 
The fifth highlighted a decrease followed by an increase in Japan, which appeared to be related to pandemic 
induced ‘employment shocks’. 
 
Added value of this study 
 
This study drew on data from 21 countries and used an analytical approach that controlled for pre-existing 
trends to determine whether patterns of suicide have changed since the COVID-19 pandemic was declared. It 
is the first study to explore the potential suicide-related impacts of COVID-19 at this scale. It shows that, in 
general, there does not appear to have been a significant increase in suicides since the pandemic began, at 
least in high- and upper middle-income countries.  
 
Implications of all the available evidence 
 
The consistency of these findings is noteworthy, and it is worth considering how they may have arisen. Many 
countries put in place additional mental health supports and financial safety nets, both of which may have 
buffered any early adverse impact of the pandemic. There is a need to ensure that efforts that may have kept 
suicide rates down until now are continued, and to remain vigilant as the longer term mental health and 
economic consequences of the pandemic unfold. There are some concerning signals that the pandemic may 
be adversely affecting suicide rates in low- and lower middle-income countries, although data are only 




middle-income countries, the impact of the pandemic on suicide may vary over time and be different for 







The COVID-19 pandemic is having profound mental health consequences,1 and there are concerns that it may 
lead to increases in suicide rates.2 We established the International COVID-19 Suicide Prevention Research 
Collaboration (ICSPRC) to monitor the global impact of COVID-19 on suicide. 
 
Relatively few studies have examined the impact of previous widespread disease outbreaks on suicide. Two 
systematic reviews have been conducted which collectively identified 10 studies, most of which were 
conducted in the United States and Hong Kong.3,4 These reviews suggest that although suicide rates may 
sometimes increase following these sorts of public health emergencies, this may not necessarily occur 
immediately, and in fact the risk may be reduced initially.  
 
We have tracked studies specific to COVID-19 and suicide through a living systematic review,5 and found that 
most have methodological limitations. Some have relied on data from unconfirmed sources, including reports 
from Nepal and Thailand based on newspaper articles citing data from police6,7 and a “secondary source”,8 
respectively. These indicated increases in suicides after the pandemic began. 
 
Other studies have used official suicide statistics for the months since the pandemic began, but have made 
comparisons to equivalent periods without accounting for underlying trends. Studies of this kind in Norway,9 
Sweden,10 South Korea,11 Tyrol (Austria),12 Leipzig (Germany)13 and Connecticut (United States)14 showed 
decreases in suicides, and one in Evros (Greece) found no change.15 Three separate studies used a similar 
approach to analysing Japanese suicide statistics. One considered children and adolescents only and found no 
evidence of an increase.16 The other two considered all age groups, and identified a decrease in the 
pandemic’s early stages,17 but highlighted an upswing in July 2020.17,18  
 
Only five studies – from Greece,19 Queensland (Australia),20 Massachusetts (United States),21 Peru22 and 
Japan23 – have used official data and accounted for temporal trends. The studies in Greece, Queensland and 
Massachusetts found that the observed and expected numbers of suicides did not differ after pandemic 
responses were introduced.19-21 The Peruvian study reported a decrease in suicides following stay-at-home 
orders.22 The Japanese study confirmed fluctuations in suicides and identified a positive association between 
pandemic-induced “employment shocks” and suicides.23 
 
In sum, the evidence to date is insufficient to indicate what the impact of COVID-19 on suicides has been or 




factors like the extent of the pandemic, the public health measures instituted to control it, the capacity of 
existing mental health services and suicide prevention programmes, and the strength of the economy and 
relief measures to support those whose livelihoods are impacted by the pandemic. There are also multiple 
other population-level influences on suicide (e.g., political unrest, economic challenges, availability of lethal 
means) that may operate independently of the pandemic or be exacerbated by it, and these may differ across 
countries. We conducted this ICSPRC study because we felt that a broader understanding of suicide patterns 
was crucial for mitigating the risk of any pandemic-related increases. We used real-time suicide data from 
multiple countries/areas-within-countries to determine whether trends in monthly suicide counts changed 







Our approach followed the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER; 
see Appendix, pages 1-2).24 We received approval from the Swansea University Medical School Research 




Real-time suicide data 
 
In many countries, there is a time-lag in official suicide data being released because of the way in which 
suicide deaths are identified and recorded in vital statistics collections. In these countries, suspected suicides 
are investigated by a coroner, medical examiner or other official to confirm the cause and manner of death, 
with or without an autopsy. The investigation process can be lengthy, resulting in data that are not 
sufficiently timely to guide suicide prevention actions. Consequently, some countries/areas-within-countries 
have developed methods for initial death classification while the investigation is ongoing, to produce real-
time suicide data. Typically, although not always, these approaches rely on police reports or death 
certificates as their primary source of evidence for the preliminary classification. These alternative or 
preliminary data sources are crucial for identifying and responding to any changes in patterns of suicide that 
may be associated with external events. Given the importance of questions about COVID-19 and suicide, we 
felt that it was critical to provide evidence from the best available real-time data sources. 
 
We sought real-time data on suicides from countries and areas-within-countries. We included the latter in 
order to maximise the number of places that could contribute to the overall picture. Establishing real-time 
suicide data collection systems is no trivial undertaking, particularly on a national level, so restricting our 
efforts to whole countries would have limited the conclusions we could draw. 
 
We used three methods to identify real-time suicide data: (a) internet searches; (b) recourse to the scientific 
literature; and (c) contact with our networks (detail below). 
 
Inclusion and exclusion criteria 
 
To be included, data from a given country/area-within-country had to come from an official government 




medical examiners office, police department, university), and be available at a monthly level from at least 1 
April 2019 to 31 July 2020 (and potentially from as far back as 1 January 2016 until as recently as 31 October 
2020). Our internet searches were restricted to countries with >3 million residents for pragmatic reasons, but 
we relaxed this rule for countries identified through the literature and our networks. Areas-within-countries 
could also be included with populations of ≤3 million. 
 
Identifying and accessing suicide data 
 
We conducted internet searches between 1 September and 1 November 2020 to identify relevant data in 
World Bank countries/economies with >3 million residents (n=135).25 We searched the official websites of 
these countries’ ministries of health, police agencies, and government-run statistics agencies or equivalents. 
We used the translated search terms “suicide” and “cause of death”. If this did not yield results, we then 
searched for publicly reported information (e.g., in news reports, on suicide prevention organisations’ 
websites) that might provide clues as to whether relevant data existed and, if so, how they might be traced. 
This involved a more general internet search using the following translated search terms: “suicide”, “[name of 
country]”, “pandemic”, “COVID” and “Corona”.  
 
We also searched the academic literature for studies reporting on suicides before and after the pandemic 
began via our living review.5 We extracted data from the publications or their cited sources, and contacted 
the authors. We also drew on the knowledge of ICSPRC members (representing 39 countries) and our World 
Health Organization (WHO) and International Association for Suicide Prevention (IASP) contacts. 
 
Publicly available data were accessed online and data that were not publicly available were provided by data 
custodians. 
 
Data storage and management 
 
We aggregated all data to the monthly level. Data were housed in a safe, secure, password-protected 
database held at Swansea University using Secure eResearch Platform technology (Adolescent Mental Health 
Data Platform [ADP]). As per the platform’s data protection protocols, access to the data was limited and 








We used interrupted time series analysis to model the trends in monthly suicides prior to COVID-19 in each 
country/area-within-country, accounting for time trends and seasonality wherever possible. Models were 
fitted using Poisson regression and accounted for possible over-dispersion using a scale parameter set to the 
model’s chi-square value divided by the residual degrees of freedom. We modelled the effect of time as a 
non-linear predictor, unless this offered no improvement beyond a linear model, in which case we used this 
instead. Non-linear time trends were estimated by selecting the best fitting model from a series of fractional 
polynomial models. Seasonality was accounted for with Fourier terms (i.e., pairs of sine and cosine 
functions). We then used each country’s model to forecast what the trend in suicides from the beginning of 
the COVID-19 period would have been had COVID-19 not occurred, calculating the expected number of 
suicides which represented the counterfactual. We compared this with the observed number of suicides in 
the same period by calculating rate ratios (and 95% confidence intervals [CIs]). In a small number of 
countries/areas-within-countries, it was not possible to account for seasonality in the model because we only 
had pre-COVID-19 data for a single year (1 January 2019 onwards). For these countries, we fitted a model 
with a linear predictor for time only. For further details of the modelling strategy, see Appendix, pages 3-17.  
 
We conducted a primary analysis and two sensitivity analyses (see Figure 1). In each analysis, we included 
data from all available months in each country/area-within-country in the pre-COVID-19 period. In the 
primary analysis, we treated 1 April 2020 as the start of the COVID-19 period and censored the data beyond 
31 July 2020. We did this to maximise data quality, recognising that there may have been under-enumeration 
of suicides in the later months with figures being subsequently updated. In sensitivity analysis 1, we retained 
1 April 2020 as the start of the COVID-19 period but relaxed the end date to include all data available in the 
COVID-19 period for each country/area-within-country up to 31 October 2020. In sensitivity analysis 2, we 
brought the start of the COVID-19 period forward to 1 March 2020 and used the original censoring date of 31 
July 2020 as the end of the COVID-19 period, recognising that the onset of COVID-19 and associated public 
health measures varied. 
 
All analyses were conducted on the Swansea University ADP Secure eResearch Platform, using Stata 16.1. The 








We sourced data from 21 countries (high income [n=16], upper-middle income [n=5]; whole country [n=10], 
area(s)-within-the-country [n=11]). Table 1 shows the countries’/areas-within-countries’ populations and the 
date that the first stay-at-home orders were implemented in each country.26 For full details of the source and 
nature of the data for each country and area-within-country, see Appendix, pages 25-33, and for the raw data 
see Appendix, page 34. 
 
Figure 2 shows the observed and expected number of suicides for April to July 2020 and presents rate ratios 
based on these numbers (see Appendix, pages 5-18 for the coefficients and standard errors of the models 
underlying the expected number of suicides). The confidence intervals surrounding the rate ratio for each 
country/area-within-country either include the null value of 1.00 or fall below the null value, indicating that 
there was no evidence of an increase in suicides during the COVID-19 period. In fact, there was statistical 
evidence of a decrease in suicides in 12 countries/areas-within-countries: New South Wales (RR 0·81, 95% CI 
0·72–0·91), Alberta (RR 0·80, 95% CI 0·68–0·93), British Columbia (RR 0·76, 95% CI 0·66–0·87), Chile (RR 0·85, 
95% CI 0·78–0·94), Leipzig (RR 0·49, 95% CI 0·32–0·74), Japan (RR 0·94, 95% CI 0·91–0·96), New Zealand (RR 
0·79, 95% CI 0·68–0·91), South Korea (RR 0·94, 95% CI 0·92–0·97), California (RR 0·90, 95% CI 0·85–0·95), 
Illinois (RR 0·79, 95% CI 0·67–0·93), Texas (RR 0·82, 95% CI 0·68–0·98) and Ecuador (RR 0·74, 95% CI 0·67–
0·82). 
 
Figure 3 shows the results of sensitivity analysis 1. Incorporating data up until the latest month available 
(October 2020) made little difference to the results from most countries/areas-within-countries. Again, the 
confidence intervals surrounding the rate ratio estimates are below 1.00 or include 1.00 in all cases, with 
three exceptions. Vienna showed a significant increase in suicides with the additional months (RR 1·31, 95% 
CI 1·08–1·59), as did Japan (RR 1.05, 95% CI 1·04–1·07) and Puerto Rico (RR 1·29, 95% CI 1·05–1·58). In each 
case, the latest month for which data were available was October. 
 
Figure 4 presents the findings from sensitivity analysis 2. Again, the picture is similar to that from our primary 
analysis. When the pandemic’s first month was considered to be March rather than April, there was no 
evidence of any increase in suicides during this redefined COVID-19 period for any country/area-within-






Our findings are relatively consistent, at least for high- and upper middle-income countries. In general, there 
does not appear to have been a significant increase in suicides during the pandemic’s early months in these 
countries. In fact, in a number of countries/areas-within-countries there seems to have been a decrease.  
 
Our findings align with the published studies from high- and upper middle-income countries that have either 
found no change in suicide rates as a function of the pandemic, or have identified decreases.9-15,19-22 Our 
findings are also consistent with emerging reports in the “grey” literature from various countries (e.g., 
England27). In some cases, this consistency is not surprising because we used the same data sources but the 
fact that we found similar patterns in many other countries is encouraging. 
 
Interpreting the findings 
 
There may be various reasons for the lack of increase in suicides since the pandemic began. Firstly, there was 
an early emphasis on the potential adverse impacts of stay-at-home orders, school closures and business 
shut-downs. Empirical evidence began to emerge from some countries that self-reported levels of 
depression, anxiety and suicidal thinking were heightened during the initial stay-at-home periods,1 but this 
does not appear to have translated into increases in suicides, at least in the countries in our study. In some 
countries, governments responded rapidly to the threat to people’s mental health, implementing 
recommended approaches like bolstering mental health services.28 Maintaining this emphasis on accessible, 
high-quality mental health care is critical. 
 
Secondly, certain protective factors may have been operating in the pandemic’s early months. Communities 
may have “rallied around” vulnerable individuals, people may have connected in new ways, and some 
relationships may have been strengthened by households spending more time with each other.28 For some 
people, everyday stresses may have been reduced during stay-at-home periods, and for others the collective 
feeling that “we’re all in this together” may have been beneficial. 
 
Finally, many countries rapidly enacted fiscal support initiatives to buffer the pandemic’s economic 
consequences. In many cases, these are now being wound back. As they lapse, previously protected 
populations may face increasing stress. Suicide rates can rise during times of economic recession,29 so it is 





A comment on outliers 
 
Vienna, Japan and Puerto Rico were outliers. We found no evidence of an increase in suicides in our primary 
analysis in any of these places, but we observed an increase in all three when we extended the observation 
period to 31 October and in Puerto Rico we noted an increase when we brought forward the pandemic’s start 
date from 1 April to 1 March. Additional contextual factors may have operated in these countries (e.g., in 
Japan several widely reported celebrity suicides that occurred during the pandemic may have exerted an 
influence; Puerto Rico has been in a deep recession since 2006 so pre-existing high levels of poverty may 
have exacerbated the pandemic’s economic impacts).  
 
Strengths and limitations 
 
Our study is the first to combine data from multiple countries to examine the early impact of COVID-19 on 
suicide, taking account of underlying trends. It involved a systematic search process and overcame the delays 
inherent in vital statistics collections by using real-time data from numerous official sources.  
 
However, it lacked representation from low- and lower middle-income countries, which account for 46% of 
the world’s suicides and may be particularly hard hit by the pandemic. Very few of these countries have good 
quality vital registrations systems and still fewer collect real-time suicide data.30 In our search, we identified 
unofficial real-time data from two lower middle-income countries (Myanmar and Tunisia) and one low-
income country (Malawi) that could not be disaggregated to the monthly level. We were unable to verify or 
use these data in our analyses, but they paint a concerning picture for two of these countries. In Malawi 
there was a 57% increase “since January” and in Tunisia there was a 5% increase in March-May. By contrast, 
in Myanmar there was a 2% decrease in January-August. 
 
Data quality may have been an issue in the countries/areas-within-countries in our study. Data from the most 
recent months in any given country/area-within-country may have been the least reliable and the most likely 
to represent undercounts, particularly if COVID-19 disrupted data collection processes. We attempted to 
overcome this by using 31 July 2020 as the end date in our primary analysis, and only using more recent 
months (to 31 October 2020) in sensitivity analysis 1. If the data in the later months were artificially low, we 
might have expected to see countries/areas-within-countries that recorded no difference in suicides in the 
primary analysis recording a decrease in sensitivity analysis 1, but this only occurred in Victoria, Thames 
Valley and Mexico City. We also conducted a post-hoc analysis in which we repeated the primary analysis but 




numbers in the latter period were likely to be updated, this might be the typical magnitude of any increase 
(see above and Appendix, page 35). This made little difference; only two areas-within-countries 
demonstrated statistical evidence of an increase in suicides where this had not been the case previously 
(New Jersey [RR 1·18, 95% CI 1·05–1·34] and Puerto Rico [RR 1·34, 95% CI 1·03–1·74]). 
 
In addition, various factors may have influenced the power and precision of our models. In particular, low 
numbers of time points and low numbers of monthly suicides in given countries or areas-within-countries 
may have resulted in models with relatively poorer power and precision. This would have had the effect of 
biasing the findings to the null and suggesting that there was no change in the number of monthly suicides 
from the pre-COVID-19 period to the COVID-19 period when in fact there may have been an increase or a 
decrease. Only five areas-within-countries had both the minimum number of pre-COVID-19 time points 
(January 2019 to March 2020) and low numbers of monthly suicides and demonstrated no change in our 
primary analysis: Vienna, Cologne and Leverkusen, Frankfort, Botucatu and Maceio. The findings from these 
areas-within-countries should be interpreted with caution. 
 
We were unable to stratify the data by age, sex or ethnicity, and the pandemic may have a differential impact 
on suicides in certain demographic groups (e.g., females,17,18 children and adolescents,17 and ethnic 
minorities14). We were also unable to explore any temporal changes in suicide methods. Additionally, we 
could not consider external factors that may have influenced suicide patterns in different countries/areas-
within-countries, including varying public health measures or economic support packages. We are planning 
future studies to address these questions. 
 
We relied on area-within-country data for 11 countries. We included these data in order to ensure 
representation from as many countries as possible and to avoid generating a picture that was biased towards 
better-resourced countries. We deliberately did not extrapolate from areas-within-countries to whole 
countries because we were aware that they were sometimes small and may have had unique suicide profiles. 
Having said this, some accounted for a large proportion of the suicides in the given country (e.g., New South 
Wales, Queensland and Victoria represent 75% of all Australian suicides) and others had larger populations 
than some of our included countries (e.g., California: 39.7 million). Additionally, data from the areas-within-
countries yielded pictures that were similar to evidence from other relevant areas. For example, the studies 
in Massachusetts and Connecticut showed no increase in suicide numbers after the pandemic began,14,21 
which is in line with our findings from United States’ jurisdictions for which we had data. Similarly, we had 




3-monthly level, but when we analysed these data separately the results were consistent with those from the 
included Australian states (RR 0·74, 95% CI 0·53–1·02). 
 
We used the same date in a given analysis to distinguish the pre-COVID-19 period from the COVID-19 period 
for all countries (1 April or 1 March 2020), potentially underestimating any effect of COVID-19 in 
countries/areas-within-countries with an earlier onset of the pandemic or public health protection measures. 
We considered using the date of the initial stay-at-home order to distinguish the pre-COVID-19 and COVID-19 
periods, but areas within a given country may have introduced stay-at-home orders at different times. 
Additionally, because we had monthly suicide counts we would have had to convert the date of initial stay-at-
home order to the beginning of the month in question or the next month. The dates fell between 23 February 




Our study is the first to examine suicides occurring in the COVID-19 context in multiple countries. It offers a 
consistent picture, albeit from high- and upper middle-income countries, of suicide numbers remaining 
unchanged or declining in the pandemic’s early months. This picture is neither complete nor final but it 
serves as the best available evidence about the pandemic’s effects on suicide to date. 
 
We need to continue to monitor real-time data and be alert to any increases in suicide, particularly as the 
pandemic’s full economic consequences emerge. We need to understand what has kept suicide numbers 
down during the pandemic’s early months, and what drives any increases if they do occur. We also need to 
recognise that suicide is not the only indicator of negative mental health impacts of the pandemic; levels of 
community distress are high and we need to make sure that people are supported. We need to redouble our 
efforts to understand the pandemic’s impact on suicides in low- and lower middle-income countries. And we 
need to make sure that we communicate our findings to governments and communities in safe, non-
sensationalist ways.31  
 
Policy-makers should heed the value of high quality, timely suicide data in suicide prevention efforts. They 
should prioritise mitigating the suicide risk factors associated with COVID-19 and take decisive action (e.g., 
resourcing mental health services, providing financial safety nets) to prevent possible longer-term 
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Beginning of initial 
stay-at-home 
period in countryc 
High-income countriesa 
Australia 25,500,000 New South Wales 8,157,700 24 Mar 2020 
Queensland 6,689,400  
Victoria 5,160,000 
Austria 8,900,000 Carinthia 560,900 16 Mar 2020 
Tyrol 757,600  
Vienna 1,911,200 
Canada 37,700,000 Alberta 4,421,900 14 Mar 2020 
British Columbia 5,147,700  
Manitoba 1,380,000 
Chile 19,100,000 Whole country Not applicable 25 Mar 2020 
Croatia 4,100,000 Whole country 4,100,000 23 Mar 2020 
England 56,300,000 Thames Valley 2,400,000 14 Mar 2020 
Estonia 1,300,000 Whole country Not applicable 9 Mar 2020 
Germany 83,800,000 Cologne and Leverkusen 1,285,500 9 Mar 2020 
Frankfurt 753,000  
Leipzig 591,000 
Italy 60,500,000 Udine and Pordenone 841,300 5 Mar 2020* 
Japan 126,500,000 Whole country Not applicable 7 Apr 2020 
Netherlands 17,100,000 Whole country Not applicable 6 Mar 2020 
New 
Zealand 
4,800,000 Whole country Not applicable 21 Mar 2020 
Poland 37,800,000 Whole country Not applicable 31 Mar 2020 
South Korea 51,200,000 Whole country Not applicable 23 Feb 2020 
Spain 46,800,000 Las Palmas 1,109,000 14 Mar 2020 
United 
States 
331,000,000 California 39,747,300 15 Mar 2020 
Illinois (Cook County) 17,000  
Louisiana 4,649,000 
New Jersey 8,936,600 
Texas (Denton, Johnson, Parker, 
Tarrant Counties) 
3,374,000 
Puerto Ricob 3,032,200 
Upper middle-income countriesa 
Brazil 212,600,000 Botucatu 140,000 14 Mar 2020 
Maceió 1,020,000 
Ecuador 17,600,000 Whole country Not applicable 17 Mar 2020 
Mexico 128,900,000 Mexico City 9,000,000 30 Mar 2020 
Peru 33,000,000 Whole country Not applicable 15 Mar 2020 
Russian 
Federation 
146,000,000 Saint Petersburg 5,468,000 5 Mar 2020 
a. Source: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-
groups 
b. Unincorporated territory of the United States 
c. Source: https://ourworldindata.org/grapher/stay-at-home-covid?tab=table&stackMode=absolute&time=2020-03-
05..latest&region=World, with amendments from local authors (indicated by *). Note that dates refer to the date 
when stay-at-home orders were first applied anywhere in the given country and that the date for areas-within-






Figure 1: Pre-COVID-19 and COVID-19 periods in the primary analysis and the two sensitivity analyses 
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Figure 2: Primary analysis: Observed and expected numbers of suicides in COVID-19 period (1 April 2020 to 
31 July 2020) based on trends in pre-COVID-19 period (at least 1 January 2019 to 31 March 2020), by 
country/area-within-country 
 
(1) Predictors for non-linear time trends and seasonality; (2) Predictors for linear time trends and seasonality; (3) Predictor for 




Figure 3: Sensitivity analysis 1: Observed and expected numbers of suicides in COVID-19 period (1 April 
2020 latest available month until 31 October 2020) based on trends in pre-COVID-19 period (at least 1 
January 2019 to 31 March 2020), by country/area-within-country 
 
(1) Predictors for non-linear time trends and seasonality; (2) Predictors for linear time trends and seasonality; (3) Predictor for 




Figure 4: Sensitivity analysis 2: Observed and expected numbers of suicides in COVID-19 period (1 March 
2020 to 31 July 2020) based on trends in pre-COVID-19 period (at least 1 January 2019 to 31 March 2020), 
by country/area-within-country 
 
(1) Predictors for non-linear time trends and seasonality; (2) Predictors for linear time trends and seasonality; (3) Predictor for 
linear time trend only; (4) Unincorporated territory of the United States. 
